Rosetta Genomics Ltd. ROSG today announced that
following the close of the U.S. stock market on Monday, October 26,
2015, the Company will file its financial results for the six months
ended June 30, 2015 on Form 6-K with the U.S. Securities and Exchange
Commission ("SEC"). The Form 6-K will include unaudited consolidated
financial statements, as well as additional information regarding the
Company. The Form 6-K will be available at www.sec.gov
and at www.rosettagenomics.com.
Kenneth A. Berlin, President and Chief Executive Officer of Rosetta
Genomics, and Ron Kalfus, Chief Financial Officer of Rosetta Genomics,
will host a conference call on Tuesday,
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in